Species differences of serum albumins: I. Drug binding sites

Pharmaceutical Research

Volumn 14, Issue 11, 1997, Pages 1607-1612

  Kosa, Takamitsu ^a   Maruyama, Toru ^a,b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

Drug binding site; Experimental anbimal serum albumins; Human serum albumin; Species difference

Indexed keywords

DIAZEPAM; HUMAN SERUM ALBUMIN; IBUPROFEN; PHENYLBUTAZONE; SERUM ALBUMIN; WARFARIN;

ARTICLE; BINDING AFFINITY; CATTLE; DOG; DRUG BINDING SITE; EQUILIBRIUM DIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RABBIT; SPECIES DIFFERENCE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; BINDING SITES; CATTLE; DIAZEPAM; DOGS; HUMANS; IBUPROFEN; PHARMACEUTICAL PREPARATIONS; PHENYLBUTAZONE; PROTEIN BINDING; RABBITS; RATS; SERUM ALBUMIN; WARFARIN;

EID: 0031472928     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012138604016     Document Type: Article

References (23)

1. U. Kragh-Hansen. Pharmacol. Rev 33:17-53 (1981).
2. T. J. Peter. All about albumin. Biochemistry, Genetics, and Medical Applications, Academic Press, California, 1996.
3. G. Sudlow, D. J. Birkett, and D. N. Wade. Mol. Pharmacol. 11:824-32 (1975).
4. X. M. He, and D. C. Carter. Nature 358:209-15 (1992).
5. J. X. Ho, E. W. Holowachuk, E. J. Norton, P. D. Twigg, and D. C. Carter. Eur. J. Biochem. 215:205-12 (1993).
6. M. R. Panjehshahin, M. S. Yates, and C. J. Bowmer. Biochem. Pharmacol. 44:873-9 (1992).
7. R. F. Chen. J. Biol. Chem. 242:173-81 (1967).
8. U. Kragh-Hansen. Mol. Pharmacol. 34:160-71 (1988).
9. F. J. Diana, K. Veronich, and A. L. Kapoor. J. Pharm. Sci. 78:195-9 (1989).
10. T. Maruyama, M. A. Furuie, S. Hibino, and M. Otagiri. J. Pharm. Sci. 81:16-20 (1992).
11. B. Honoré and R. Brodersen. Mol. Pharmacol. 25:137-50 (1984).
12. S. Chakrabarti, R. Laliberte, and J. Brodeur. Biochem. Pharmacol. 25:2515-21 (1976).
13. H. W. Dirr and J. C. Schabort. Biochim. Biophys. Acta 913:300-7 (1987).
14. K. J. Fehske, U. Schlafer, U. Wollert, and W. E. Muller. Mol. Pharmacol. 21:387-93 (1982).
15. K. Yamasaki, T. Maruyama, U. Kragh-Hansen, and M. Otagiri. Biochim. Biophys. Acta 1295:147-57 (1996).
16. C. F. Chignell and D. K. Starkweather. Pharmacology 5:235-44 (1971).
17. J. J. Lima. Drug Metab. Dispos. 16:563-7 (1988).
18. F. M. Belpaire, R. A. Braeckman, and M. G. Bogaert. Biochem. Pharmacol. 33:2065-9 (1984).
19. E. M. Seller, M. L. Lang-Sellers, and J. Koch-Weser. Biochem. Pharmacol. 26:2445-7 (1977).
20. T. Maruyama, C. C. Lin, K. Yamasaki, T. Miyoshi, T. Imai, M. Yamasaki, and M. Otagiri. Biochem. Pharmacol. 45:1017-26 (1993).
21. S. Wanwimolruk, D. J. Birkett, and P. M. Brooks. Mol. Pharmacol. 24:458-63 (1983).
22. K. K. Gambhir, R. H. McMenamy, and F. Watson. J. Biol. Chem. 250:6711-19 (1975).
23. J. H. Lin. Drug Metab. Dispos. 23:1008-21 (1995).